Myelosuppression

15 registered clinical trials studyying Myelosuppression — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cance NCT06992739	The First Affiliated Hospital of Xiamen University	Phase 2
Recruiting	Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy NCT07205536	Affiliated Hospital of Nantong University	Phase 2
Recruiting	Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastat NCT06929936	The First Affiliated Hospital of Xiamen University	Phase 2
Recruiting	A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppressio NCT06699472	Fudan University	Phase 2
Not Yet Recruiting	Current Survey on Chemotherapy-Related Myelosuppression and Clinical Management in Chinese County-level Tumor NCT06641934	The First Affiliated Hospital of Xinxiang Medical College	—
Recruiting	Trilaciclib Prevents Myelosuppression With Chemoradiotherapy NCT06490081	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 2
Not Yet Recruiting	A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and NCT05780294	Sun Yat-sen University	Phase 3
Unknown	A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Specia NCT04905329	Moscow Clinical Scientific Center	—
Unknown	Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia NCT03846414	CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.	—
Unknown	Investigation of the Correlation Between Plasma Concentration of Linezolid Antibiotic and Treatment Response a NCT03126890	National Taiwan University Hospital	—
Completed	Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia NCT02692742	Myelo Therapeutics GmbH	Phase 2
Completed	Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-in NCT05442177	Taichung Tzu Chi Hospital	—
Terminated	Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Re NCT02375334	Wake Forest University Health Sciences	—
Unknown	Profonycia - Honey for Improving Quality of Patient's Life Receiving Chemotherapy NCT00524797	Ziv Hospital	N/A
Completed	Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma NCT00151866	Sanquin Research & Blood Bank Divisions	Phase 3